Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
Experience of 12-month therapy with acarbose, glibenclamide, and metformin in uncontrolled Saudi Type diabetic patients
Experience of 12-month therapy with acarbose, glibenclamide, and metformin in uncontrolled Saudi Type diabetic patients
Document Language
:
English
Abstract
:
We conducted this study to evaluate the effect of adding acarbose to a regimen of maximum glibenclamid and metformin combination on the glycaemic control of Saudi Type 2 diabetic patients. A total of 176 patients were included with mean age of 56 years and mean duration of diabetic of 8.7 years. There was a significant drop in the median fasting and postprandial blood glucose level and HbA, from 11.6 mmol/L,17.8 mmol/L (9.9%), to 6.9 mmol/L,10 mmol/L (7.1%), respectively (p <0.001 for all). There was no significant change in the median body mass index or serum lipids during the study periode. Gastrointestinal side-effects developed in 34% of patients but none of the patients developed any hypoglycaemic attacks. Acarbose can be combined successfully with glibenclamide and metformin for better glycaemic control in Type 2 diabetic patients.
ISSN
:
1319-1004
Journal Name
:
Diabetes International
Volume
:
11
Issue Number
:
1
Publishing Year
:
2001 AH
2001 AD
Article Type
:
Article
Added Date
:
Monday, March 1, 2010
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
أ.د. دعـــد أكبر
Akbar, Prof. Daad
Researcher
Doctorate
Files
File Name
Type
Description
25769.doc
doc
Back To Researches Page